NASDAQ:UPC Universe Pharmaceuticals (UPC) Stock Price, News & Analysis $1.50 -0.03 (-1.63%) As of 11:54 AM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsNews and TrendsSEC Filings About Universe Pharmaceuticals Stock (NASDAQ:UPC) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get UPC alerts:Sign Up Key Stats Today's Range$1.47▼$1.4950-Day Range$1.39▼$4.8652-Week Range$1.33▼$17.96Volume4,017 shsAverage Volume656,791 shsMarket Capitalization$7.56 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Universe Pharmaceuticals Inc. is a pharmaceutical company focused on the development, manufacture, marketing and sale of products derived from traditional Chinese medicine. The company offers prescription and over-the-counter medicines, as well as certain health-related products, primarily for the Chinese market. Its product portfolio is designed to address a range of therapeutic areas, including respiratory conditions, orthopedic disorders, cardiovascular and cerebrovascular diseases, and gynecological conditions. Universe Pharmaceuticals markets its products under its own brands and distributes them through a combination of direct sales and third-party distributors. Based in Xi’an, Shaanxi Province, China, the company traces its operating history to the late 1990s and has built its business around the modernization and commercialization of traditional Chinese medicine. Universe Pharmaceuticals began trading publicly on the Nasdaq under the symbol UPC in 2021.AI Generated. May Contain Errors. Read More Universe Pharmaceuticals Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks14th Percentile Overall ScoreUPC MarketRank™: 0.68450039339 of 5 starsUniverse Pharmaceuticals scored higher than 14% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingUniverse Pharmaceuticals has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageUniverse Pharmaceuticals has only been the subject of 1 research reports in the past 90 days.Read more about Universe Pharmaceuticals' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Book Value per Share RatioUniverse Pharmaceuticals has a P/B Ratio of 0.02. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.96% of the float of Universe Pharmaceuticals has been sold short.Short Interest Ratio / Days to CoverUniverse Pharmaceuticals has a short interest ratio ("days to cover") of 0.14, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Universe Pharmaceuticals has recently increased by 38.44%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldUniverse Pharmaceuticals does not currently pay a dividend.Dividend GrowthUniverse Pharmaceuticals does not have a long track record of dividend growth. News and Social Media3.0 / 5News SentimentN/A News SentimentUniverse Pharmaceuticals has a news sentiment score of 1.79. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.55 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 1 news article for Universe Pharmaceuticals this week, compared to 1 article on an average week. Company Ownership0.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Universe Pharmaceuticals insiders have not sold or bought any company stock.Percentage Held by Insiders57.38% of the stock of Universe Pharmaceuticals is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions0.18% of the stock of Universe Pharmaceuticals is held by institutions.Read more about Universe Pharmaceuticals' insider trading history. Receive UPC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Universe Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. UPC Stock News HeadlinesUniverse Pharmaceuticals (UPC) AI Stock AnalysisNovember 2, 2026 | tipranks.comLaw Offices of Howard G. Smith Announces Investigation of Universe Pharmaceuticals INC.October 12, 2026 | businesswire.comYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.November 13 at 1:00 AM | Profits Run (Ad)The Law Offices of Frank R. Cruz Announces Investigation of Universe Pharmaceuticals INC. (UPC) on Behalf of InvestorsOctober 7, 2026 | tmcnet.comThe Law Offices of Frank R. Cruz Announces Investigation of Universe Pharmaceuticals INC.October 7, 2026 | businesswire.comUniverse Pharmaceuticals shares rise 22.6% premarket with no new catalyst identifiedSeptember 2, 2026 | msn.comUniverse Pharmaceuticals (UPC) stock soars over 38% after-hours: Here's what's going onSeptember 2, 2026 | msn.comUniverse Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:UPCJuly 18, 2026 | benzinga.comSee More Headlines UPC Stock Analysis - Frequently Asked Questions How have UPC shares performed this year? Universe Pharmaceuticals' stock was trading at $3.81 on January 1st, 2026. Since then, UPC stock has decreased by 59.3% and is now trading at $1.55. When did Universe Pharmaceuticals' stock split? Universe Pharmaceuticals's stock reverse split before market open on Wednesday, November 13th 2024.The 1-15 reverse split was announced on Wednesday, November 13th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, November 12th 2024. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split. When did Universe Pharmaceuticals IPO? Universe Pharmaceuticals (UPC) raised $30 million in an initial public offering on Tuesday, March 23rd 2021. The company issued 5,000,000 shares at $5.00-$7.00 per share. Univest Securities, LLC served as the underwriter for the IPO. How do I buy shares of Universe Pharmaceuticals? Shares of UPC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings7/29/2026Today11/13/2026Fiscal Year End9/30/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (2m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 UPC's financial health is in the Yellow zone, according to TradeSmith. UPC has been in this zone for over 2 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNASDAQ:UPC Previous SymbolNYSE:UPC CIK1809616 Webwww.universe-pharmacy.com Phone86-0796-8403309FaxN/AEmployees216Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.04 Current Ratio4.05 Quick Ratio3.90 Sales & Book Value Annual Sales$17.86 million Price / Sales0.42 Cash FlowN/A Price / Cash FlowN/A Book Value$99.64 per share Price / Book0.02Miscellaneous Outstanding Shares5,020,000Free Float2,141,000Market Cap$7.56 million OptionableN/A Beta1.84 Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report This page (NASDAQ:UPC) was last updated on 11/13/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredTrump’s EO to send this $5 stock ripping higher…?President Trump's December executive order declared space a national security and economic priority, fueling a...Traders Agency | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredTrump compared today's market to 1929President Trump warned of a 1929-style depression if Democrats won control of Congress. On November 3, they di...USA Capital Gold | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredURGENT: If you own a home, please review the map below.More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards...Paradigm Press | SponsoredUranium Mine Flood That Sparked a 2006 Price Surge ReturnsIn 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This pa...Digest Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Universe Pharmaceuticals INC Please log in to your account or sign up in order to add this asset to your watchlist. Share Universe Pharmaceuticals With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
